Viemed Healthcare (VMD) Common Equity (2018 - 2026)

Viemed Healthcare (VMD) has reported Common Equity for 9 consecutive years, with $146.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Common Equity rose 3.06% year-over-year to $146.0 million; the trailing twelve-month figure through Jun 2026 stood at $146.0 million (up 3.06% YoY), and the FY2025 full-year result was $143.5 million, up 7.67% from the prior year.
• Common Equity held at $146.0 million in Q2 2026 per VMD's latest filing, from $145.8 million in the prior quarter.
• Across five years, Common Equity topped out at $146.0 million in Q2 2026 and bottomed at $93.2 million in Q2 2022.
• Historically, Common Equity has averaged $119.7 million across 5 years, with a median of $118.7 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Common Equity climbed 2.4% in 2022, then climbed 17.61% in 2025.
• Over 5 years, Common Equity stood at $97.1 million in 2022, then advanced by 17.3% to $113.9 million in 2023, then advanced by 17.04% to $133.3 million in 2024, then grew by 7.67% to $143.5 million in 2025, then rose by 1.7% to $146.0 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $146.0 million, $145.8 million, and $143.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.